Albumin-mediated alteration of plasma zinc speciation by fatty acids modulates blood clotting in type-2 diabetes
Open Access
- 1 February 2021
- journal article
- research article
- Published by Royal Society of Chemistry (RSC) in Chemical Science
- Vol. 12 (11), 4079-4093
- https://doi.org/10.1039/d0sc06605b
Abstract
Zn2+ is an essential regulator of coagulation and is released from activated platelets. In plasma, the free Zn2+ concentration is fine-tuned through buffering by human serum albumin (HSA). Importantly, the ability of HSA to bind/buffer Zn2+ is compromised by co-transported non-esterified fatty acids (NEFAs). Given the role of Zn2+ in blood clot formation, we hypothesise that Zn2+ displacement from HSA by NEFAs in certain conditions (such as type 2 diabetes mellitus, T2DM) impacts on the cellular and protein arms of coagulation. To test this hypothesis, we assessed the extent to which increasing concentrations of a range of medium- and long-chain NEFAs reduced Zn2+-binding ability of HSA. Amongst the NEFAs tested, palmitate (16 : 0) and stearate (18 : 0) were the most effective at suppressing zinc-binding, whilst the mono-unsaturated palmitoleate (16 : 1c9) was markedly less effective. Assessment of platelet aggregation and fibrin clotting parameters in purified systems and in pooled plasma suggested that the HSA-mediated impact of the model NEFA myristate on zinc speciation intensified the effects of Zn2+ alone. The effects of elevated Zn2+ alone on fibrin clot density and fibre thickness in a purified protein system were mirrored in samples from T2DM patients, who have derranged NEFA metabolism. Crucially, T2DM individuals had increased total plasma NEFAs compared to controls, with the concentrations of key saturated (myristate, palmitate, stearate) and mono-unsaturated (oleate, cis-vaccenate) NEFAs positively correlating with clot density. Collectively, these data strongly support the concept that elevated NEFA levels contribute to altered coagulation in T2DM through dysregulation of plasma zinc speciation.Keywords
Funding Information
- British Heart Foundation (FS/15/42/31556, PG/15/9/31270)
- Commonwealth Scholarship Commission (MWCN-2017-294)
This publication has 68 references indexed in Scilit:
- Correspondence of Fatty Acid and Drug Binding Sites on Human Serum Albumin: A Two-Dimensional Nuclear Magnetic Resonance StudyBiochemistry, 2013
- Zinc: An important cofactor in haemostasis and thrombosisThrombosis and Haemostasis, 2013
- Functional Analysis of Leishmania Cyclopropane Fatty Acid SynthetasePLOS ONE, 2012
- Effects of zinc supplementation on diabetes mellitus: a systematic review and meta-analysisDiabetology & Metabolic Syndrome, 2012
- A Molecular Mechanism for Modulating Plasma Zn Speciation by Fatty AcidsJournal of the American Chemical Society, 2012
- Redistribution of labile plasma zinc during mild surgical stress in the ratTranslational Research, 2011
- Free zinc ions outside a narrow concentration range are toxic to a variety of cells in vitroExperimental Biology and Medicine, 2010
- Structure, Properties, and Engineering of the Major Zinc Binding Site on Human AlbuminJournal of Biological Chemistry, 2009
- Crystal structures of human serum albumin complexed with monounsaturated and polyunsaturated fatty acidsJournal of Molecular Biology, 2001
- PLASMA FREE FATTY ACID TURNOVER RATE IN OBESITYActa Medica Scandinavica, 1969